Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-20-020887
Filing Date
2020-12-10
Accepted
2020-12-10 19:14:04
Documents
2
Period of Report
2020-12-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 3151
2 poa_gray.htm EX-24 8804
  Complete submission text file 0001567619-20-020887.txt   13399
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Issuer) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address
GRAY SUSANNAH (Reporting) CIK: 0001833453 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39782 | Film No.: 201381793